The research base is real, peer-reviewed, and published in indexed journals
Melittin has high membrane-perturbing action, which accounts for its anti-inflammatory, anti-microbial, and cancer-fighting abilities (Roversi et al., 2023)
(2001) Journal of Clinical Pharmacology n=34 Pharmacokinetic study establishing AOD 9604 peak plasma levels, elimination half-life, and subcutaneous bioavailability
Not for human or veterinary use & not FDA-approved
DFO upregulates GPX4, xCT, and GSH, curbs gliocyte overgrowth, enhances long-term motor function, and mitigates iron overload (Yao et al., 2019)
Notably, treatment with Vas2870, an inhibitor of NADPH oxidase, significantly increased the survival rate of HFD-fed mice subjected to LPS by ameliorating renal injury and inhibiting ferroptosis